← Back to Search
Drug Absorption Through Mucosal Membranes: Effect Of Mucosal Route And Penetrant Hydrophilicity
D. C. Corbo, J. Liu, Y. Chien
Published 2004 · Chemistry, Medicine
Download PDFAnalyze on Scholarcy
The influence of mucosal route and penetrant hydrophilicity on the in vivo absorption of a model lipophilic compound, progesterone, was investigated in ovariectomized rabbits. The absorption rate and systemic bioavailability of progesterone and its monohydroxy, dihydroxy, and trihydroxy derivatives were evaluated and compared following oral, nasal, rectal, and vaginal administrations. Nasal delivery resulted in a significantly higher rate and extent of progesterone absorption than oral, rectal, or vaginal administration. The rate and extent of mucosal absorption decreased as penetrant hydrophilicity increased for the nasal, rectal, and vaginal routes. The results of this investigation indicate that the absorption characteristics of a lipophilic compound, such as progesterone, are influenced by the properties of both the mucosa and the drug.
This paper references
Mechanism of nasal absorption of drugs. II: Absorption of L-tyrosine and the effect of structural modification on its absorption.
C. Huang (1985)
Determination of partition coefficients of glucocorticosteroids by high-performance liquid chromatography.
J. C. Caron (1984)
Nasal delivery of progestational steroids in ovariectomized rabbits: I. progesterone — comparison of pharmacokinetics with intravenous and oral administration
D. C. Corbo (1988)
Nasal absorption of natural contraceptive steroids in rats-progesterone absorption.
A. Hussain (1981)
The effect of molecular size on the nasal absorption of water‐soluble compounds in the albino rat
A. Fisher (1987)
Steroid metabolism by rat nasal mucosa: studies on progesterone and testosterone.
E. Brittebo (1984)
Analysis of structural requirements for the absorption of drugs and macromolecules from the nasal cavity.
C. Mcmartin (1987)
Plasma levels of progesterone after vaginal, rectal, or intramuscular administration of progesterone.
S. J. Nillius (1971)
Serum progesterone levels following vaginal administration of progesterone during the luteal phase.
E. Myers (1987)
Intravaginal administration of progesterone: enhanced absorption after estrogen treatment.
B. Villanueva (1981)
Effect of progesterone and 17-hydroxyprogesterone caproate on normal corpus luteum function.
S. Aksel (1974)
Bioavailability of progesterone enhanced by intranasal spraying
G. David (2005)
Intranasal drug delivery by spray and drops
J. G. Hardy (1985)
Effectiveness of vaginal administration of progesterone
C. Glazener (1985)
This paper is referenced by
Nasal drug delivery–a review
Twarita Deshpande (2012)
Effectiveness of pirotiodecane, absorption enhancer, on nasal absorption in rabbits.
H. Otake (2005)
Different routes of progesterone administration and polycystic ovary syndrome: A review of the literature
V. Unfer (2005)
Safety and efficacy of intranasally administered medications in the emergency department and prehospital settings.
M. Corrigan (2015)
PROGESTERONE Different routes of progesterone administration and polycystic ovary syndrome : A review of the literature
V. Unfer (2005)
Intranasal delivery: An approach to bypass the blood brain barrier
S. Talegaonkar (2004)
Nasal Delivery of High Molecular Weight Drugs
Y. Ozsoy (2009)
Nasal delivery of recombinant human growth hormone with pheroid technology
J. D. Steyn (2006)
Nasal Delivery of Biopharmaceuticals
E. Yuba (2014)
REVIEW ON NASAL DRUG DELIVERY SYSTEM WITH RECENT ADVANCEMNT
P. Sharma (2011)
Pilot Study: Absorption and Efficacy of Multiple Hormones Delivered in a Single Cream Applied to the Mucous Membranes of the Labia and Vagina
R. Glaser (2008)
Nasal Administration of Compounds Active in the Central Nervous System Exploring the Olfactory Pathway
M. Dahlin (2000)
[The principles and the routes of progestagenes' administration in PCOS].
J. Krzysiek (2005)
Intranasal delivery: physicochemical and therapeutic aspects.
H. Costantino (2007)
Parenteral administration of progestins for hormonal replacement therapy
A. Nath (2009)
Vaginal Permeability and Enzymatic Activity Studies in Normal and Ovariectomized Rabbits
F. Acartürk (2004)
Protein and Peptide Delivery through Respiratory Pathway
H. Tandel (2011)
Tissue-based in vitro and ex vivo models for vaginal permeability studies
A. Machado (2016)
Chlorpyrifos PBPK/PD model for multiple routes of exposure
T. Poet (2014)
FORMULATION AND EVALUATION OF IN-SITU NASAL GEL OF RIZATRIPTAN BENZOATE
Piyush Agarwal (2017)
Einfluss von Formulierungsparametern auf die nasale Verfügbarkeit von Natriumcromoglicat, Xylometazolinhydrochlorid und Oxymetazolinhydrochlorid
Sigrun Krase (2003)
Chitosan and its derivatives as the carrier for intranasal drug delivery
Jiaojiao Ding (2012)
Bioavailability of intranasal drug delivery system
S. B. Bhise (2008)
Techniques of Intranasal Steroid Use
M. Benninger (2004)
Comparative Pharmaceutical Evaluation of Candesartan and Candesartan Cilexetil: Physicochemical Properties, In Vitro Dissolution and Ex Vivo In Vivo Studies
A. Amer (2017)
Desenvolvimento de uma formulação tópica contendo fluconazol nanoencapsulado para o tratamento de candidíase vulvovaginal
T. A. Reis (2014)
Permeability issues in nasal drug delivery.
P. Arora (2002)
Effective screening of chemical penetration enhancers for transdermal drug delivery
V. K. Rachakonda (2008)
INTRANASAL DRUG DELIVERY SYSTEM : A REVIEW
Pratikkumar A. Mistri (2012)
Vaginal Drug Delivery
J. Neves (2010)
Inhalation Drug Therapy: Emerging Trends in Nasal and Pulmonary Drug Delivery
M. Lalan (2019)
Oral Delivery of Proteins and Peptides: Concepts and Applications
Gaurang Patel (2011)See more